Authors: Gervois, P Vu-Dac, N Kleemann, R Kockx, M Dubois, G Laine, B Kosykh, V Fruchart, JC Kooistra, T Staels, B

Citation: P. Gervois et al., Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta, J BIOL CHEM, 276(36), 2001, pp. 33471-33477

Authors: Kleemann, R Hausser, A Geiger, G Mischke, R Burger-Kentischer, A Flieger, O Johannes, FJ Roger, T Calandra, T Kapurniotu, A Grell, M Finkelmeier, D Brunner, H Bernhagen, J

Citation: R. Kleemann et al., Intracellular action of the cytokine MIF to modulate AP-1 activity and thecell cycle through Jab1, NATURE, 408(6809), 2000, pp. 211-216

Authors: Kleemann, R Rorsman, H Rosengren, E Mischke, R Mai, NT Bernhagen, J

Citation: R. Kleemann et al., Dissection of the enzymatic and immunologic functions of macrophage migration inhibitory factor - Full immunologic activity of N-terminally truncatedmutants, EUR J BIOCH, 267(24), 2000, pp. 7183-7192

Authors: Kleemann, R Goossens, L Reder, E Quirke, JF

Citation: R. Kleemann et al., Depletion kinetics of clenbuterol hydrochloride in competition horses, EQUINE V J, 31(4), 1999, pp. 339-341

Authors: Nautrup, BP Justus, C Philipp, H Kleemann, R

Citation: Bp. Nautrup et al., Investigations on efficacy and tolerance of a subcutaneous and subsequent oral treatment of meloxicam in dogs, TIER UMSCH, 54(4), 1999, pp. 199

Authors: Kleemann, R Kapurniotu, A Mischke, R Held, J Bernhagen, J

Citation: R. Kleemann et al., Characterization of catalytic centre mutants of macrophage migration inhibitory factor (MIF) and comparison to Cys81Ser MIF, EUR J BIOCH, 261(3), 1999, pp. 753-766